Effect of inhaled N-acetylcysteine on the pulmonary complications after liver transplantation

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14005169

Enrollment

Unknown

Registered

2014-08-19

Start date

1990-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver disease

Interventions

experimental group:Atomization inhalation of N-acetylcysteine

control group:none

atomized control group:Atomization inhalation of Sterile Water for Injection

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) age older than 18 years; (2) can obtain informed consent; (3) no other organ failure; (4) the patients have respiratory diseases that cause thick mucous secretions (such as chronic bronchitis).

Exclusion criteria

Exclusion criteria: (1) age older than 65 years; (2) can not obtain informed consent; (3) have another organ failure; (4) having another surgery except liver transplantation; (5) severe intraoperative hemorrhage (blood loss more than 10000ml).

Design outcomes

Primary

Measure	Time frame
incidence of Pulmonary complications;duration time of ICU;expression of inflammatory biomarkers (TNF-alpha, IL-8, IL-10);	—

Countries

China

Contacts

Public ContactZiqing Hei

heiziqing@sina.com+86 13925020330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026